Company Overview
Anbio Biotechnology is a global medical technology leader dedicated to decentralizing
diagnostics to improve patient outcomes. The Company specializes in a versatile in vitro
diagnostics (IVD) portfolio spanning multiple core technology platforms, including FIA, CLIA,
RT-PCR, LFIA, LAMP, and Dry Chemistry. With a strategic presence in over 100 countries across
Europe, APAC, and the Americas, Anbio bridges the gap between traditional laboratory and
immediate site-of-care results by delivering affordable, clinically-grade accuracy in under 60
minutes to support clinical laboratories, point-of-care providers, and at-home wellness markets
worldwide.
Latest Press Releases
Anbio Biotechnology to
Participate in KeyBanc Capital Markets Healthcare Forum Healthcare Forum
March 18, 2026
View All News
Latest Financial Results
FY 2025
Fiscal Year Ended December 31, 2025
Anbio Biotechnology
If you are interested, you can fill out the questionnaire. We will contact
you later.
Contact us
Stock Information
February 27, 2026 4:00 PM EST
Nasdaq: NNNN
SYMBOL
Previous Close
Volume
Today’s Open
Average Volume (10 days)
undefined - undefined
Day's Range
Market Cap
undefined - undefined
52 Week Range
Total Shares Outstanding
Leadership
Having accumulated decades of collective experience across a
variety
of fields, our leadership team is the source of our success.
of fields, our leadership team is the source of our success.
VIEW MANAGEMENT TEAM
VIEW BOARD OF DIRECTORS
Investor FAQs
What is Anbio’s Business?
Anbio Biotechnology is a global medical technology leader dedicated to decentralizing diagnostics to improve patient
outcomes. The Company specializes in a versatile in vitro diagnostics (IVD) portfolio spanning multiple core technology
platforms, including FIA, CLIA, RT-PCR, LFIA, LAMP, and Dry Chemistry. With a strategic presence in over 100 countries
across Europe, APAC, and the Americas, Anbio bridges the gap between traditional laboratory and immediate site-of-
care results by delivering affordable, clinically-grade accuracy in under 60 minutes to support clinical laboratories,
point-of-care providers, and at-home wellness markets worldwide.
Where is Anbio’s corporate headquarters and what are the locations that Anbio operates in?
Anbio is headquartered at Friedrich-Ebert-Anlage 35–37, 60327 Frankfurt am Main, Germany. The Company
operates globally, with a presence in Europe and across APAC and the Americas.
When was the Company founded?
The Company was founded in 2021.
On which exchange is Anbio’s stock traded and what is the ticker symbol?
Anbio trades on the NASDAQ exchange under the ticker “NNNN.”
When does Anbio’s fiscal year end?
The fiscal year ends on December 31st.
Who is Anbio’s independent auditor?
GGF CPA LTD.
Who is Anbio’s US legal counsel?
Ortoli Rosenstadt LLP is acting as counsel to our company regarding U.S. securities law matters.
Where can I find all the SEC filings for Anbio?
Information on all SEC filings may be found on the tab "Financials" on this site or by using the SEC’s
EDGAR database found at the SEC’s website, https://www.sec.gov/edgar/.
Company Overview
Anbio Biotechnology is a global medical technology leader dedicated to decentralizing diagnostics to improve patient outcomes. The Company specializes in a versatile in vitro diagnostics (IVD) portfolio spanning multiple core technology platforms, including FIA, CLIA, RT-PCR, LFIA, LAMP, and Dry Chemistry. With a strategic presence in over 100 countries across Europe, APAC, and the Americas, Anbio bridges the gap between traditional laboratory and immediate site-of-care results by delivering affordable, clinically-grade accuracy in under 60 minutes to support clinical laboratories, point-of-care providers, and at-home wellness markets worldwide.
Latest Press Releases
Anbio Biotechnology to
Participate in KeyBanc Capital Markets Healthcare Forum
Healthcare Forum
March 18, 2026
View All News
Latest Financial Results
FY 2025
Fiscal Year Ended December 31, 2025
Anbio Biotechnology
If you are interested, you can fill out the
questionnaire. We will contact
you later.
Contact us
Stock Information
February 27, 2026 4:00 PM EST
SYMBOL
Nasdaq: NNNN
Previous Close
Volume
Today’s Open
Average Volume (10 days)
Day's Range
undefined - undefined
Market Cap
52 Week Range
undefined - undefined
Total Shares Outstanding
Leadership
Having accumulated decades of
collective experience across a variety of
fields, our leadership team is the source
of our success.
VIEW MANAGEMENT TEAM
VIEW BOARD OF DIRECTORS
Investor FAQs
